We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-14.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.38B
AUM Growth
-$1.44B
Cap. Flow
-$114M
Cap. Flow %
-1.78%
Top 10 Hldgs %
23.74%
Holding
150
New
4
Increased
49
Reduced
28
Closed
15

Top Sells

Rank Stock Value
1
W icon
Wayfair
W
+$63.5M
2
MGA icon
Magna International
MGA
+$61.9M
3
ASND icon
Ascendis Pharma A/S
ASND
+$48.6M
4
ASML icon
ASML
ASML
+$34.6M
5
YETI icon
Yeti Holdings
YETI
+$28M

Sector Composition

Rank Sector Weight
1 Healthcare 33.31%
2 Technology 29.3%
3 Industrials 14.62%
4 Consumer Discretionary 5.73%
5 Utilities 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
101
Sysco
SYY
$40.6B
$13.2M 0.21%
161,298
+29,900
+23% +$2.42M
ICPT
102
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$13M 0.2%
800,000
+472,556
+144% +$7.4M
APTV.PRA
103
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
-87,500
Closed -$13.2M
VCYT icon
104
Veracyte
VCYT
$4.77B
$11.5M 0.18%
418,000
-233,000
-36% -$6.66M
IEX icon
105
IDEX
IEX
$17.2B
$11.2M 0.18%
58,400
TRGP icon
106
Targa Resources
TRGP
$57.6B
$11.1M 0.17%
+146,700
New +$9.27M
VECT
107
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$11M 0.17%
2,339,044
SHLS icon
108
Shoals Technologies Group
SHLS
$1.49B
$10.6M 0.17%
620,832
-1,226,068
-66% -$21.2M
EGP icon
109
EastGroup Properties
EGP
$11.3B
$10.3M 0.16%
50,800
+20,600
+68% +$4.08M
ANNX icon
110
Annexon
ANNX
$863M
$9.9M 0.16%
3,626,508
+776,508
+27% +$4.78M
XPO icon
111
XPO
XPO
$23.4B
$8.37M 0.13%
193,545
-176,715
-48% -$7.39M
ROIV icon
112
Roivant Sciences
ROIV
$24.9B
$8.18M 0.13%
1,690,300
+990,300
+141% +$6.53M
GRMN
113
Garmin
GRMN
$57.4B
$7.24M 0.11%
61,000
LOB icon
114
Live Oak Bancshares
LOB
$1.97B
$6.97M 0.11%
136,983
-129,145
-49% -$8.26M
WMS icon
115
Advanced Drainage Systems
WMS
$10.5B
$6.9M 0.11%
58,078
ARE icon
116
Alexandria Real Estate Equities
ARE
$9.15B
$6.78M 0.11%
33,700
+12,400
+58% +$2.42M
DSGN icon
117
Design Therapeutics
DSGN
$788M
$6.46M 0.1%
400,000
PHVS icon
118
Pharvaris
PHVS
$2.37B
$5.66M 0.09%
302,619
+57,694
+24% +$1.02M
MNDY icon
119
monday.com
MNDY
$3.73B
$5.14M 0.08%
+32,500
New +$6.11M
IMGN
120
DELISTED
Immunogen Inc
IMGN
$4.76M 0.07%
1,000,000
SHW icon
121
Sherwin-Williams
SHW
$83.7B
$4.62M 0.07%
18,500
KBH icon
122
KB Home
KBH
$3.45B
$4.59M 0.07%
141,700
PHAT icon
123
Phathom Pharmaceuticals
PHAT
$731M
$4.58M 0.07%
336,223
FOUR icon
124
Shift4
FOUR
$4.26B
$4.33M 0.07%
70,000
-19,000
-21% -$1M
FRLN
125
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$3.97M 0.06%
240,413
+8,036
+3% +$149K

Similar funds

Eventide Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Eventide Asset Management held 150 positions worth $6.38B, down 18% from $7.83B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q1 2022 filing shows 4 new, 49 increased, 28 reduced and 15 closed positions. Its largest new stake was Walker & Dunlop: 121,935 shares worth $15.8M. The largest sale was Wayfair, an estimated $63.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2022 buy was Walker & Dunlop: 121,935 shares worth $15.8M.
  • Eventide Asset Management added most to Guardant Health in Q1 2022, an estimated $29.2M increase.
  • Eventide Asset Management's biggest Q1 2022 reduction was Ascendis Pharma A/S, cutting an estimated $48.6M.
  • Eventide Asset Management fully exited Wayfair in Q1 2022, selling an estimated $63.5M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.38B portfolio in Q1 2022.
  • Eventide Asset Management opened 4 new positions and closed 15 in Q1 2022.
  • Eventide Asset Management's portfolio value fell 18% quarter-over-quarter to $6.38B.

Based on Eventide Asset Management's 13F filing for Q1 2022, filed 16 May 2022.